Next Article in Journal
A New Sampling Approach for the Detection of Swine Influenza a Virus on European Sow Farms
Next Article in Special Issue
Serial Measurement of Serum Pancreatic Lipase Immunoreactivity, Feline Trypsin-like Immunoreactivity, and Cobalamin Concentrations in Kittens
Previous Article in Journal
Physiotherapy Improves Dogs’ Quality of Life Measured with the Milan Pet Quality of Life Scale: Is Pain Involved?
Previous Article in Special Issue
The Effects of Bacterial Lipopolysaccharide (LPS) on Turkey Poults: Assessment of Biochemical Parameters and Histopathological Changes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence and Risk Factors for Bartonella spp. and Haemoplasma Infections in Cats from Greece

by
Kassiopi Christina G. Kokkinaki
1,*,
Manolis N. Saridomichelakis
1,
Vassilis Skampardonis
2,
Antonia Mataragka
3,
John Ikonomopoulos
3,
Leonidas Leontides
2,*,
Mathios E. Mylonakis
4,
Joerg M. Steiner
5,
Jan S. Suchodolski
5 and
Panagiotis G. Xenoulis
1,5
1
Clinic of Medicine, Faculty of Veterinary Science, University of Thessaly, 224 Trikalon Str., GR-43132 Karditsa, Greece
2
Laboratory of Epidemiology, Biostatistics and Economics of Animal Production, Faculty of Veterinary Science, University of Thessaly, 224 Trikalon Str., GR-43132 Karditsa, Greece
3
Laboratory of Anatomy and Physiology of Farm Animals, Department of Animal Science, Agricultural University of Athens, 75 Iera Odos, Votanikos, GR-11855 Athens, Greece
4
Companion Animal Clinic, School of Veterinary Medicine, Aristotle University of Thessaloniki, 11 Stavrou Voutyra Str., GR-54627 Thessaloniki, Greece
5
Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A & M University, College Station, TX 77843, USA
*
Authors to whom correspondence should be addressed.
Vet. Sci. 2022, 9(7), 337; https://doi.org/10.3390/vetsci9070337
Submission received: 24 May 2022 / Revised: 19 June 2022 / Accepted: 30 June 2022 / Published: 3 July 2022
(This article belongs to the Special Issue Veterinary Clinical Pathology and Diagnostic Research)

Abstract

:

Simple Summary

Bartonellosis and haemoplasmosis are diseases with global impact on the health of domestic cats and of zoonotic importance. This is the first study investigating the risk factors for Bartonella spp. and haemoplasma species infections in cats from Greece. In addition, this study determined the serologic and molecular prevalence of Bartonella spp. and haemoplasma species infections in different populations of cats living in different regions of Greece. A total of 452 cats were enrolled into the study. Blood was collected from each cat for the serological detection of Bartonella henselae antibodies and the molecular detection of Bartonella spp. and haemoplasma species infections. Overall, the seroprevalence of B. henselae was 35.4%, while the molecular prevalence of Bartonella spp. and haemoplasma species was 2.9% and 19%, respectively. The results of this study indicate that cats with partial or exclusive outdoor access and cats with flea infestation are at the greatest risk for B. henselae seropositivity. Furthermore, cats living in warmer regions such as Attica and Crete are at the greatest risk. Lack of ectoparasiticide use was identified as a risk factor for haemoplasma species infection. This suggests that the use of ectoparasiticides in cats may be an effective means of preventing haemoplasma species infection in cats.

Abstract

Bartonellosis and haemoplasmosis are vector-borne diseases with global impact on the health of domestic cats and of zoonotic importance. The aim of this study was to describe the epidemiological aspects of various populations of cats infected with Bartonella spp. or haemoplasma species. The populations evaluated included client-owned cats, stray cats and cats that live in breeding catteries in Greece. A total of 452 cats were prospectively enrolled into the study. A commercially available indirect immunofluorescence antibody testkit was used for the detection of Bartonella henselae IgG antibodies in serum. PCRs for the detection of Bartonella spp. and haemoplasma species DNA in the blood were also performed in a subgroup of 242 of the 452 cats. Risk factors for B. henselae seropositivity and infection with the haemoplasma species were determined using multivariable analysis. Overall, 160 (35.4%) of the 452 cats were seropositive for B. henselae. Seven (2.9%) and 46 (19%) of the 242 cats were PCR-positive for Bartonella spp. and haemoplasma species, respectively. The factors associated with B. henselae seropositivity, based on multivariate analysis, included older age, outdoor access, living region and flea infestation. Non-administration of ectoparasiticides was associated with haemoplasma species infection. This study shows a high prevalence of seropositivity for B. henselae and a relatively high prevalence of infection with haemoplasma species. Therefore, it is necessary to establish optimal strategies for the prevention of Bartonella spp. and haemoplasma species infections, considering the high-risk groups of cats identified in this study.

1. Introduction

Bartonellosis and haemoplasmosis are vector-borne diseases with global impact on the health of domestic cats and of zoonotic importance.
Bartonella species are small, Gram-negative intracellular bacteria and cats are the main reservoir of Bartonella henselae, Bartonella clarridgeiae and Bartonella koehlerae and accidental hosts for Bartonella quintana, Bartonella bovis and Bartonella vinsonii subsp. berkhoffii. The most common species infecting cats is B. henselae, which is the main causative agent of cat-scratch disease in humans [1]. The major mode of transmission among cats is by exposure to flea bites (Ctenocephalides felis) or faeces, and uncommonly by aggressive interactions among cats [2,3,4].
The reported serological and molecular prevalence of Bartonella spp. varies considerably, ranging between 0–85% and 0–83.5% [5], respectively, depending on the geographical location and study population. The most well-documented risk factor for Bartonella spp. infection is flea infestation [6]. In addition, younger cats, especially those under 2 years of age, are more likely to present with bacteraemia compared to older cats, while the latter appear to be more likely to become seropositive compared to the former [6,7,8,9,10,11,12]. Cats with outdoor access are more likely to become infected due to increased access to flea-infested environments [11,13,14,15,16,17,18]. Similarly, multi-cat households are a risk factor for Bartonella infection due to the increased number of potential hosts (other infected cats) and vectors [19].
Haemoplasmas are haemotropic mycoplasmas that infect erythrocytes. The main haemoplasma species currently known to infect cats are Mycoplasma haemofelis, Candidatus Mycoplasma haemominutum and Candidatus Mycoplasma turicensis. Although the natural mode of transmission of haemoplasma species among cats is not clear, arthropod vectors including C. felis and aggressive interactions with infected cats have been suggested [20].
The reported molecular prevalence of haemoplasma species infection ranges between 4% and 43% [21]. In several studies, male gender has been reported as a risk factor for haemoplasma species infection [20,22,23]. From a behavioural perspective, between-cat aggression is higher in male cats than in females, leading to a greater risk of bite wounds and haemoplasma transmission. Outdoor access and cat bite abscesses have also been suggested as risk factors [22]. Cats living outdoors or having outdoor access have increased chances of aggressive interactions with haemoplasma-infected cats and exposure to fleas. Non-pedigree cats are more likely to become infected compared to purebred cats [24]. The results of several studies indicate that older cats are more likely to be infected compared to younger cats [22,25]. A possible explanation for this association could be that older cats have more chance of acquiring chronic subclinical infections during their lives. As already mentioned, C. felis has been implicated in the transmission of feline haemoplasmas, despite the limited evidence for transmission by fleas under experimental or natural conditions [26]. However, the regular use of ectoparasiticides has been associated with a decreased risk of haemoplasma infection [27].
Only limited data are available on the epidemiology of Bartonella spp. and haemoplasma species in cats from Greece, with a total of four reported studies for both infections [28,29,30,31]. The risk factors for these two vector-borne pathogens were not investigated in any of these studies. In addition, these studies included cats living in certain parts of the country and admitted to veterinary clinics for veterinary care, likely representing a somewhat biased population that does not reflect the general feline population.
The objectives of the present study were to determine the seroprevalence of B. henselae and the molecular prevalence of Bartonella spp. and haemoplasma species in different populations of cats living in different regions of Greece, and to assess the risk factors for B. henselae seropositivity and haemoplasma species PCR positivity. Based on previously reported data, we hypothesized that the major risk factor for B. henselae seropositivity and haemoplasma species PCR positivity would be flea infestation.

2. Materials and Methods

2.1. Ethics Approval

The study protocol was reviewed and approved by the Animal Ethics Committee of the Faculty of Veterinary Science, University of Thessaly (13/16-6-15). Handling of these animals was in compliance with the European Communities Council Directive 2010/63/EU and state laws.

2.2. Study Population

Cats from four different geographic areas of Greece (i.e., Attica, Thessaly, Crete and Macedonia) (Figure 1) were prospectively enrolled by three clinicians between November 2013 and November 2016 and divided into three groups: client-owned cats, stray cats and cats living in breeding catteries. A subgroup of these cats was described in a recently published study investigating the prevalence of FeLV antigenemia and FIV seropositivity, as well as the clinical signs and the haematological and biochemical findings associated with Feline leukemia virus and feline immunodeficiency virus infection [32]. The cats were presented by their owners (client-owned or breeding cattery cats) or by two cat-rescue groups (stray cats) for wellness examination, vaccination, neutering and/or medical treatment. Stray cats often originated from cat-dense environments (i.e., rescue colonies) and their age was estimated based on body size, dentition and other physical characteristics.
The inclusion criteria for the cats in all groups included: (a) a body weight of ≥0.5 kg; and (b) an informed consent form signed by the owner or the rescuer. Cats were considered healthy based on a normal physical examination and no recent history of disease. Cats who presented with systemic clinical (anorexia, depression, lethargy), gastrointestinal (vomiting, diarrhoea), ocular, neurological or dermatological signs (skin lesions and/or pruritus) were considered sick.
For the serological detection of B. henselae IgG antibodies, cats that fulfilled the above two criteria were enrolled on a sequential basis, regardless of their health status. For the molecular detection of Bartonella spp. and haemoplasma species, the cats were randomly selected from the initially enrolled cats using a randomisation table.
Signalment and historical data were collected using a standardised questionnaire (Questionnaire S1) and a thorough physical examination was performed for each cat by one of three authors (KGK, PGX, MEM). Historical information included: a) signalment; (b) geographic origin and travel history; (c) prior and current ownership; (d) living conditions (indoors, outdoors); (e) diet (dry food, canned food, home cooked food, raw meat); (f) vaccination status (fully vaccinated, partially vaccinated, unvaccinated); (g) parasite prevention status (regular use of ectoparasiticides, intermittent use, non-use); (h) prior medical problems; (i) previous treatments; (j) chief presenting complaint; (k) present health status (e.g., weight loss, reduced appetite, faecal characteristics).
The minimum required study population size to detect at least two times higher odds of B. henselae seropositivity among flea infested than non-infested cats, with 80% power at the 95% confidence level, was determined to be 418 cats (StatCalc, EpiInfo ver. 7.2.5; Centers for Disease Control and Prevention (CDC), Atlanta, Georgia).

2.3. Sample Collection and Laboratory Analyses

A total of 5 mL of blood was collected by jugular venipuncture from adult cats and 3.5 mL from young kittens. One millilitre of blood was sequentially transferred into two EDTA-anticoagulated tubes. One sample was used for haematology, while the other was stored at −80 °C for PCR. The remaining blood was transferred in an anticoagulant-free tube, and the serum was harvested following centrifugation at 3000 rpm for 20 min. The serum aliquots were stored at −80 °C until biochemical analysis and indirect fluorescent antibody test (IFAT) were conducted.
Haematology was performed using one of three different haematology analysers (Sysmex pocH-100i, Norderstedt, Germany; ADVIA 2120i Siemens Healthcare GmbH, Erlangen, Germany; ADVIA 120 Siemens Healthcare GmbH, Erlangen, Germany), depending on the geographic area of the sampling, and the results were classified as normal, increased or decreased, based on the reference intervals of each laboratory. For most cats, the differential white blood cell count was calculated manually, and the inspection for platelet aggregates was carried out in Diff-Quik (Merck, Darmstadt, Germany)-stained blood smears, whereas for the remaining cats (n = 25), it was based on the results of analysis using the ADVIA 2120i analyser, Siemens Healthcare GmbH, Erlangen, Germany. All haematologic analyses were performed within 12 h of blood collection. Biochemical analyses were performed using an automated chemistry analyser (Roche/Hitachi MODULAR ANALYTICS D 2400 module, Roche Diagnostics, Rotkreuz, Switzerland).

2.4. Serologic Testing

Bartonella henselae IgG antibodies were detected using commercially available IFAT kits (Biopronix Product Line, Agrlolabo S.p.a., Torino, Italy) according to the manufacturer’s instructions as previously described [33,34]. For each assay run, negative and positive controls that contained the IFAT kit were included. The cut-off value was 1/64 for B. henselae. All slides were examined by fluorescence microscopy at 40× magnification (Olympus, Tokyo, Japan).

2.5. Molecular Analyses

DNA was extracted from whole blood using the Nucleospin Tissue Kit (Macherey-Nagel GmbH & Co. KG, Düren, Germany), based on the instructions provided by the manufacturer, and stored at −20 °C until use.
The assessment of the DNA’s purity and integrity was conducted with submerged gel electrophoresis and image analysis using the Bio-Rad ChemiDoc XRS+ Molecular Imager (Bio-Rad Laboratories Inc., Des Plaines, IL USA). The DNA solutions were submitted for analysis of optical density count at 260/280 nm, using a NanoDrop 8000 Spectrophotometer (Thermo Fisher Scientific Inc., Watham, MA, USA). DNA solutions for which this part of the pre-analytical assessment provided evidence of fragmentation or low quality were discarded, and DNA isolation was repeated from the original sample. Samples with acceptable DNA quality were processed for the assessment of the presence of PCR inhibitors using a PCR assay targeting actin as a housekeeping gene [35]. DNA solutions that were negative for the housekeeping gene were diluted in ddH2O (1:5 v/v) and the analysis was repeated. Depending on the outcome, the diluted DNA solutions were either discarded and DNA isolation was repeated from the original sample, or processed for the detection of the study pathogens.
The DNA isolation and PCRs were performed using positive and negative controls integrated into each stage of the analysis (DNA/PCR positive and negative controls). With regard to DNA isolation, the control samples consisted of 500 μL ddH2O (DNA C-), and whole blood of equal volume (500 μL) that was PCR-positive for the respective pathogen, confirmed by sequence analysis of the PCR product (DNA C+). For the PCR, the positive and negative controls consisted of DNA solutions that were confirmed PCR-positive for each assay (PCR C+) or 5 μL of the DNA elution buffer (PCR C-), respectively.
PCR was performed in an Applied Biosystems Verity 96-well Thermal Cycler (Thermo Fisher Scientific Inc., Watham, MA, USA). Real-time PCR was performed in a Roche LightCycler 2.0 (Roche, Germany). The PCR products were analysed by submerged electrophoresis using 2% agarose gels stained with ethidium bromide (0.5 μg/mL) and visualised using a Bio-Rad ChemiDoc XRS+ Molecular Imager (Bio-Rad Laboratories Inc., Des Plaines, IL, USA). For confirmation of the specificity of the amplification products, approximately 20% of the PCR products were submitted for sequence analysis, which was conducted on both strands using the Applied Biosystems BigDye Terminator Cycle Sequencing Kit and PRISM 377 DNA Sequencer (Thermo Fisher Scientific Inc., Watham, MA, USA). The results were analysed and compared to deposited sequences in the GenBank database (http://www.ncbi.nlm.nih.gov; accessed on 12 January 2018) using the Basic Local Alignment Search Tool (BLAST) of the National Center for Biotechnology Information (NCBI).
The validation of the PCR assays used in our study was based on the ad hoc laboratory analysis of previously published methods. This analysis included the assessment of the method specificity using in silico analysis of the relevant oligonucleotide primers and limit of detection (LoD), as previously described [36]. The LoD was assessed on serial dilutions of DNA isolated from whole-blood samples that were PCR-positive to the respective assays, confirmed by the sequence analysis of the PCR products. The analysis was conducted in line with the provisions of the quality standard ISO17025:2017 (ISO/IEC 17025 (2017). General requirements for the competence of testing and calibration laboratories. International Organization for Standardization/International Electrotechnical Committee, Geneva).

2.6. PCR Protocol for Detection of Bartonella spp.

The target sequence was a 209 base-pair fragment of the Bartonella ssrA gene (Forward: GCTATGGTAATAAATGGACAATGAAATAA, Reverse: GACGTGCTTCCGCATAGTTGTC) [28]. A 25 μL mixture for each PCR reaction was performed with the Kapa Taq PCR kit following the standard protocol suggested by the manufacturer. The amplification profile consisted of an initial denaturation step at 95 °C for 5 min, followed by 30 cycles of incubation at 95 °C for 30 sec, 60 °C for 45 sec and a final elongation step at 72 °C for 5 min.

2.7. PCR Protocol for Detection of Haemoplasma Species

The target sequence was a fragment of the haemoplasma 16S-rRNA gene (Forward: ACGAAAGTCTGATGGAGCAATA, Reverse: ACGCCCAATAAATCCGRATAAT) [37]. A 25 μL mixture for each PCR reaction was performed with the Kapa Taq PCR kit, following the standard protocol suggested by the manufacturer. A hot-start PCR was performed, starting with 5 min at 95 °C. The amplification profile consisted of an initial denaturation step at 95 °C for 5 min followed by 30 cycles of incubation at 95 °C for 30 sec, 60 °C for 45 sec and a final elongation step at 72 °C for 5 min.

2.8. Statistical Analysis

The analyses were only performed on cats with complete information on all variables considered. Cats with missing data were excluded. In the univariate analyses, the categorical data regarding signalment and historical information in B. henselae seropositive cats or haemoplasma species PCR-positive cats were compared to those of B. henselae seronegative cats or haemoplasma species PCR-negative cats, respectively, by either Pearson’s χ2 or Fisher’s exact test. The normality of the distribution of the continuous variables was evaluated with the Kolmogorov–Smirnov test. Therefore, normally distributed data are presented as means ± standard deviation and were compared between PCR-positive or seropositive and PCR-negative or seronegative cats using two-sample t-tests. Variables whose distribution deviate from normality are presented as medians and ranges and were compared between PCR-positive or seropositive and PCR-negative or seronegative cats using Mann–Whitney U tests.
Subsequently, variables relating to signalment and historical information that were different at p < 0.25 between B. henselae-seropositive cats or haemoplasma species PCR-positive and B. henselae-seronegative or haemoplasma species PCR-negative cats, respectively, in the univariate analyses were selected as candidates for initial logistic regression modelling. The initial models were subsequently reduced in a stepwise manner until only the variables significant at p < 0.05 remained. Odds ratios (OR) derived from the reduced models were interpreted as measures of increased risk of seropositivity or PCR positivity. The analyses were conducted using Stata 13 (Stata Corp, College Station, TX, USA) and SPSS 23 for Windows (IBM Corp, Armonk, NY, USA).

3. Results

3.1. Serological Testing for B. henselae (n = 452)

A total of 452 cats were enrolled. The signalment and historical data are presented in Table 1. Of the 452 cats, 160 (35.4%; 95%CI 31–39.8%) were found to be seropositive for B. henselae. The univariate associations between seropositivity for B. henselae and signalment-historical data are presented in Table 2.

3.2. Risk Factors for B. henselae Seropositivity

Several factors were found to be significantly associated with B. henselae seropositivity in the multivariate analysis (Table 3). Seropositive cats were significantly older than seronegative cats; moreover, cats living outdoors were significantly more likely to be seropositive than cats living indoors. In addition, cats living in Attica and Crete were significantly more likely to be seropositive than cats living in Thessaly. Flea infestation was also found to be risk factor for B. henselae seropositivity.

3.3. PCR Validation

PCR validation showed that the PCR assays do not lead to false-positive results [28,37,38]. The analytical sensitivity of the PCR assay designed for the detection of DNA belonging to B. quintana, B. henselae, B. bovis and B. elizabethae was determined at 5 fg of DNA/reaction [38]. The relevant information is not available in connection with haemoplasma species, because the conditions for its in vitro isolation and accurate enumeration have not been described [37]. With regards to the in silico analysis of the oligonucleotide primers used for PCR assays, the specificity was found to be 100% based on sequence comparison using the Basic Local Alignment Search Tool (Primer-BLAST) [39] of the National Center for Biotechnology Information (NCBI). At the 98% level of confidence, the LoD determined ad hoc for the study PCR assays was 0.01 and 0.02 ng/mL for Bartonella spp. and haemoplasma species, respectively.

3.4. PCR Testing for Bartonella spp. and Haemoplasma Species (n = 242)

A total of 242 cats were selected for the molecular detection of Bartonella spp. and haemoplasma species infections. The signalment and historical data are presented in Table 1.
Of the 242 cats, a total of 7 (2.9%; 95%CI 0.7–5%) and 46 (19%; 95%CI 14.1–23.9%) were found to be PCR-positive for Bartonella spp. and haemoplasma species, respectively. Of the PCR-positive cats, three (1.2% of the total 242 cats; 95%CI 0.2–2.6%) had concurrent PCR-positive results for Bartonella spp. and haemoplasma species. The univariate associations between haemoplasma species and signalment/historical data are presented in Table 4.

3.5. Risk Factors for Haemoplasma Species PCR Positivity

The multivariate analysis indicated that cats who had not been treated with a preventative ectoparasiticide were significantly more likely to be haemoplasma species PCR-positive than cats who had been treated with ectoparasiticides (Table 3).

4. Discussion

This is one of the largest prospective studies on natural infection with Bartonella spp. and haemoplasma species in cats from Greece. In addition, this is the first study investigating the risk factors for these two vector-borne pathogens in cats from Greece. Overall, 35.4% of the cats were seropositive for B. henselae, while 2.9% and 19% of the cats were PCR-positive for Bartonella spp. and haemoplasma species, respectively. Older age, outdoor access, living region and flea infestation were significant predictors of B. henselae seropositivity. Non-administration of ectoparasiticides was associated with PCR positivity for haemoplasma species.
The haemoplasma species prevalence identified here by PCR is similar to the results from a previous prospective study in cats from Greece, where the prevalence was reported to be 20.6% [29]. However, in another study from Greece that assessed Leishmania infantum infection in 50 clinically healthy cats and 50 sick cats, the authors reported a seroprevalence of B. henselae of only 4% [31]. The higher prevalence in our study could be explained by differences in the study population. In the previous study, cats were enrolled from two certain areas of Greece (central and northern Greece) and included cats examined at veterinary clinics or enrolled in spay/neuter programmes. In our study, we enrolled a large number of cats of all ages, lifestyles and health status. In parallel with this, we aimed to have a study population representative, as much as possible, of the general feline population in Greece. Therefore, we included cats living both in the continental mainland and insular regions of Greece; regarding the former, we included cats living in the north (Thessaloniki), in the central (Thessaly), and in the south mainland (Attica) and regarding the latter, we included cats living on the largest island of Greece (Crete). Furthermore, the sites selected were based on the presence of colonies of stray cats and on the willingness of animal welfare organisations and local veterinarians to collaborate with us. More recently, in a study investigating the occurrence of zoonotic parasites and vector-borne pathogens in stray cats living in selected areas of Greece, the authors reported a seroprevalence of B. henselae of 58.8% [30]. Furthermore, in a retrospective study of 100 cats from Greece, 8.5% and 14.9% were PCR-positive for Bartonella spp. and haemoplasma species, respectively [28]. The seroprevalence for Bartonella spp. in cats has been reported to be 0–68% in Europe [40], 0–85.2% in the USA [10], 37% in Australia [41] and 11–59% in Africa [42]. Studies have reported an overall PCR-based prevalence of feline infection with haemoplasma species of 32.1% in South Africa [43], 27.2% in Australia [44], 26.4% in Asia [45], 12–27% in the USA [46] and 4–43% in Europe [47]. The variability of serologic and molecular prevalence among these studies may reflect differences in the demographics and the geographic origin of the cats, in the accuracy of the diagnostic tests, the presence of illness and/or anaemia and/or the overtime changes in the prevalence of these infections. For example, contact with other cats and outdoor access have been shown to increase the risk of Bartonella spp. infection. Furthermore, studies where cats were sampled from lower income areas have shown a high prevalence of vector-borne diseases compared to cats living in higher income areas, because such cats may be less likely to receive preventive ectoparasiticide treatment. Furthermore, different real-time PCR assays have been developed for Bartonella detection and have been used in studies. They have differences in their sensitivity, probes used and range of species detected.
In the current study, B. henselae-seropositive cats were significantly older than B. henselae-seronegative cats. This is consistent with previous studies suggesting that older cats are more commonly infected with B. henselae, possibly due to the fact that they have more time to be exposed to the microorganism [6,18].
Our study showed that cats with outdoor access were more likely to be B. henselae-seropositive compared to cats living strictly indoors and this is in agreement with previous reports, likely reflecting increased access to flea-infested environments [6,14].
In addition, cats living in Attica and Crete were significantly more likely to be B. henselae-seropositive than cats living in Thessaly. Although the reason for this finding is not known, it may be due to the slightly different environmental conditions in Thessaly compared to Attica and Crete. Attica and Crete have slightly higher average temperatures (about 2–3 degrees) almost all months of the year. Ctenocephalides felis, the most important arthropod vector for the transmission of Bartonella spp. in cats, is strongly influenced by environmental factors including temperature and humidity, and these environmental conditions may be more favourable in Attica and Crete than in Thessaly. Cats infested with fleas were more likely to be B. henselae-seropositive compared to cats without flea infestation. Many studies have documented that B. henselae is naturally transmitted among cats by the flea C. felis or by flea faeces [2], while C. felis was found to be the major flea species affecting cats in Greece [48]. In a recent study from Greece involving the molecular detection of Bartonella spp. in fleas and ticks parasitising cats and dogs from Attica, the authors demonstrated the presence of B. henselae and B. clarridgeiae in C. felis fleas from cats and dogs in Greece [49]. Our results indicating flea infestation as a risk factor for B. henselae seropositivity is in accordance with the results of previous studies [14,16,19]. In a recent study on zoonotic vector-borne pathogens in cats from Italy, a risk analysis revealed that cats with flea infestation were 3.5 times more likely to be B. henselae-seropositive than cats without flea infestation [6].
Cats who had not been on a preventative ectoparasiticide were more likely to be PCR-positive for haemoplasmas than cats previously treated with an ectoparasiticide. The mode of natural transmission of haemoplasma species in cats is still elusive, but fleas and other arthropod vectors are suspected to be involved. The cat flea C. felis has been implicated in feline haemoplasma transmission, but this has not been definitively proven experimentally. In an experimental study conducted in 2005 [50], a very transient M. haemofelis infection was reported via the haematophagous activity of fleas, but clinical and haematological changes consistent with M. haemofelis infection were not observed in the recipient cat. Furthermore, ticks have been proposed as potential vectors, since feline haemoplasma species have been found in ticks collected from cats [51]; however, no clear evidence for their role in the natural transmission of feline haemoplasma species exists. Similarly, mosquitoes have been proposed as vectors for feline haemoplasma species, but there is no evidence of the biologic transmission of feline haemoplasma species.
This study has some limitations. Although the cats enrolled were randomly selected, selection bias might still exist. Only cats that were examined at veterinary clinics and had an informed consent form signed by their owner or the rescuer were included. Owners willing to participate in research are more aware of the risks of vector-borne infections and the implementation of strict flea control measures, so they are more likely to use ectoparasiticides on their animals. Therefore, cats being on a preventative ectoparasiticide may have been overrepresented in our study. Another limitation of our study is that the diagnostic sensitivity and specificity of the IFAT kit used for the detection of B. henselae IgG antibodies were unknown. In addition, the lack of identification of Bartonella spp. and haemoplasmas on a species level in this study prevented the potential expansion of the spectrum of these pathogens affecting felines in Greece.

5. Conclusions

This study showed a high prevalence of seropositivity for B. henselae and a relatively high prevalence of haemoplasma species infection. The results of this study indicate that cats with partial or exclusive outdoor access and cats with flea infestation are at higher risk for B. henselae seropositivity. Furthermore, cats living in warmer regions such as Attica and Crete are at higher risk for B. henselae seropositivity. The lack of ectoparasiticide use was identified as a risk factor for haemoplasma species PCR positivity. This suggests that the use of ectoparasiticides in cats may be an effective mean of preventing haemoplasma species infection in cats.
Future prospective studies in naturally infected cats are warranted in order to investigate the clinical and clinicopathologic relevance of different species of Bartonella and haemoplasmas in cats in Greece and other geographic locations.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vetsci9070337/s1, Questionnaire S1: Questionnaire for cat owners.

Author Contributions

Conceptualization, K.C.G.K., M.N.S. and P.G.X.; methodology, K.C.G.K., M.N.S., V.S., A.M., J.I., L.L. and P.G.X.; software, K.C.G.K., V.S. and L.L.; validation, K.C.G.K., V.S., A.M., J.I. and L.L.; formal analysis, K.C.G.K., M.N.S., V.S., L.L. and P.G.X.; investigation, K.C.G.K., M.N.S., V.S., A.M., J.I., L.L., M.E.M., J.M.S., J.S.S. and P.G.X.; resources, K.C.G.K., M.N.S., V.S., J.I., L.L., M.E.M., J.M.S., J.S.S. and P.G.X.; data curation, K.C.G.K., M.N.S., V.S., A.M., J.I., L.L., M.E.M., J.M.S., J.S.S. and P.G.X.; writing—original draft preparation, K.C.G.K.; writing—review and editing, M.N.S., V.S., A.M., J.I., L.L., M.E.M., J.M.S., J.S.S. and P.G.X.; visualization, K.C.G.K., M.N.S. and P.G.X.; supervision, M.N.S. and P.G.X.; project administration, M.N.S. and P.G.X.; funding acquisition, K.C.G.K., M.N.S. and P.G.X. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted at the Clinic of Medicine of the Faculty of Veterinary Science, University of Thessaly, Greece, and the study protocol was reviewed and approved by the Animal Ethics Committee of the Faculty of Veterinary Science, University of Thessaly (AUP number: 13/16-6-15).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Acknowledgments

The authors wish to thank Chrisi Simou and Theodoros Bamplenis for their help with enrolment of the cats into the study, and George Kazakos for his advice on the protocol for the chemical restraint of the cats.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Boulouis, H.J.; Chang, C.C.; Henn, J.B.; Kasten, R.W.; Chomel, B.B. Factors associated with the rapid emergence of zoonotic Bartonella infections. Vet. Res. 2005, 36, 383–410. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Bouhsira, E.; Ferrandez, Y.; Liu, M.; Franc, M.; Boulouis, H.J.; Biville, F. Ctenocephalides felis an in vitro potential vector for five Bartonella species. Comp. Immunol. Microbiol. Infect. Dis. 2013, 36, 105–111. [Google Scholar] [CrossRef] [PubMed]
  3. Chomel, B.B.; Kasten, R.W.; Floyd-Hawkins, K.; Chi, B.; Yamamoto, K.; Roberts-Wilson, J.; Gurfield, A.N.; Abbott, R.C.; Pedersen, N.C.; Koehler, J.E. Experimental transmission of Bartonella henselae by the cat flea. J. Clin. Microbiol. 1996, 34, 1952–1956. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Lappin, M.R.; Davis, W.L.; Hawley, J.R.; Brewer, M.; Morris, A.; Stanneck, D. A flea and tick collar containing 10% imidacloprid and 4.5% flumethrin prevents flea transmission of Bartonella henselae in cats. Parasit. Vectors 2013, 6, 26. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Alvarez-Fernandez, A.; Breitschwerdt, E.B.; Solano-Gallego, L. Bartonella infections in cats and dogs including zoonotic aspects. Parasit. Vectors 2018, 11, 624. [Google Scholar] [CrossRef]
  6. Morelli, S.; Crisi, P.E.; Di Cesare, A.; De Santis, F.; Barlaam, A.; Santoprete, G.; Parrinello, C.; Palermo, S.; Mancini, P.; Traversa, D. Exposure of client-owned cats to zoonotic vector-borne pathogens: Clinic-pathological alterations and infection risk analysis. Comp. Immunol. Microbiol. Infect. Dis 2019, 66, 101344. [Google Scholar] [CrossRef]
  7. Ueno, H.; Muramatsu, Y.; Chomel, B.B.; Hohdatsu, T.; Koyama, H.; Morita, C. Seroepidemiological survey of Bartonella (Rochalimaea) henselae in domestic cats in Japan. Microbiol. Immunol. 1995, 39, 339–341. [Google Scholar] [CrossRef]
  8. Zangwill, K.M.; Hamilton, D.H.; Perkins, B.A.; Regnery, R.L.; Plikaytis, B.D.; Hadler, J.L.; Cartter, M.L.; Wenger, J.D. Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N. Engl. J. Med. 1993, 329, 8–13. [Google Scholar] [CrossRef]
  9. Koehler, J.E.; Glaser, C.A.; Tappero, J.W. Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir. JAMA 1994, 271, 531–535. [Google Scholar] [CrossRef]
  10. Jameson, P.; Greene, C.; Regnery, R.; Dryden, M.; Marks, A.; Brown, J.; Cooper, J.; Glaus, B.; Greene, R. Prevalence of Bartonella henselae antibodies in pet cats throughout regions of North America. J. Infect. Dis. 1995, 172, 1145–1149. [Google Scholar] [CrossRef]
  11. Chomel, B.B.; Abbott, R.C.; Kasten, R.W.; Floyd-Hawkins, K.A.; Kass, P.H.; Glaser, C.A.; Pedersen, N.C.; Koehler, J.E. Bartonella henselae prevalence in domestic cats in California: Risk factors and association between bacteremia and antibody titers. J. Clin. Microbiol. 1995, 33, 2445–2450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Breitschwerdt, E.B.; Kordick, D.L. Bartonella infection in animals: Carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection. Clin. Microbiol. Rev. 2000, 13, 428–438. [Google Scholar] [CrossRef] [PubMed]
  13. Nutter, F.B.; Dubey, J.P.; Levine, J.F.; Breitschwerdt, E.B.; Ford, R.B.; Stoskopf, M.K. Seroprevalences of antibodies against Bartonella henselae and Toxoplasma gondii and fecal shedding of Cryptosporidium spp, Giardia spp, and Toxocara cati in feral and pet domestic cats. J. Am. Vet. Med. Assoc. 2004, 225, 1394–1398. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Guptill, L.; Wu, C.C.; HogenEsch, H.; Slater, L.N.; Glickman, N.; Dunham, A.; Syme, H.; Glickman, L. Prevalence, risk factors, and genetic diversity of Bartonella henselae infections in pet cats in four regions of the United States. J. Clin. Microbiol. 2004, 42, 652–659. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Finkelstein, J.L.; Brown, T.P.; O’Reilly, K.L.; Wedincamp, J., Jr.; Foil, L.D. Studies on the growth of Bartonella henselae in the cat flea (Siphonaptera: Pulicidae). J. Med. Entomol. 2002, 39, 915–919. [Google Scholar] [CrossRef] [PubMed]
  16. Chomel, B.B.; Carlos, E.T.; Kasten, R.W.; Yamamoto, K.; Chang, C.C.; Carlos, R.S.; Abenes, M.V.; Pajares, C.M. Bartonella henselae and Bartonella clarridgeiae infection in domestic cats from The Philippines. Am. J. Trop. Med. Hyg. 1999, 60, 593–597. [Google Scholar] [CrossRef] [Green Version]
  17. Branley, J.; Wolfson, C.; Waters, P.; Gottlieb, T.; Bradbury, R. Prevalence of Bartonella henselae bacteremia, the causative agent of cat scratch disease, in an Australian cat population. Pathology 1996, 28, 262–265. [Google Scholar] [CrossRef]
  18. Zhang, Y.; Zhang, Z.; Lou, Y.; Yu, Y. Prevalence of hemoplasmas and Bartonella species in client-owned cats in Beijing and Shanghai, China. J. Vet. Med. Sci 2021, 83, 793–797. [Google Scholar] [CrossRef]
  19. Gurfield, A.N.; Boulouis, H.J.; Chomel, B.B.; Kasten, R.W.; Heller, R.; Bouillin, C.; Gandoin, C.; Thibault, D.; Chang, C.C.; Barrat, F.; et al. Epidemiology of Bartonella infection in domestic cats in France. Vet. Microbiol. 2001, 80, 185–198. [Google Scholar] [CrossRef]
  20. Sykes, J.E.; Drazenovich, N.L.; Ball, L.M.; Leutenegger, C.M. Use of conventional and real-time polymerase chain reaction to determine the epidemiology of hemoplasma infections in anemic and nonanemic cats. J. Vet. Intern. Med. 2007, 21, 685–693. [Google Scholar] [CrossRef]
  21. Sykes, J.E. Feline hemotropic mycoplasmas. Vet. Clin. N. Am. Small Anim. Pract. 2010, 40, 1157–1170. [Google Scholar] [CrossRef] [PubMed]
  22. Willi, B.; Boretti, F.S.; Baumgartner, C.; Tasker, S.; Wenger, B.; Cattori, V.; Meli, M.L.; Reusch, C.E.; Lutz, H.; Hofmann-Lehmann, R. Prevalence, risk factor analysis, and follow-up of infections caused by three feline hemoplasma species in cats in Switzerland. J. Clin. Microbiol. 2006, 44, 961–969. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Harrus, S.; Klement, E.; Aroch, I.; Stein, T.; Bark, H.; Lavy, E.; Mazaki-Tovi, M.; Baneth, G. Retrospective study of 46 cases of feline haemobartonellosis in Israel and their relationships with FeLV and FIV infections. Vet. Rec. 2002, 151, 82–85. [Google Scholar] [CrossRef] [PubMed]
  24. Jenkins, K.S.; Dittmer, K.E.; Marshall, J.C.; Tasker, S. Prevalence and risk factor analysis of feline haemoplasma infection in New Zealand domestic cats using a real-time PCR assay. J. Feline Med. Surg. 2013, 15, 1063–1069. [Google Scholar] [CrossRef]
  25. Tasker, S.; Binns, S.H.; Day, M.J.; Gruffydd-Jones, T.J.; Harbour, D.A.; Helps, C.R.; Jensen, W.A.; Olver, C.S.; Lappin, M.R. Use of a PCR assay to assess the prevalence and risk factors for Mycoplasma haemofelis and ‘Candidatus Mycoplasma haemominutum’ in cats in the United Kingdom. Vet. Rec. 2003, 152, 193–198. [Google Scholar] [CrossRef]
  26. Woods, J.E.; Wisnewski, N.; Lappin, M.R. Attempted transmission of Candidatus Mycoplasma haemominutum and Mycoplasma haemofelis by feeding cats infected Ctenocephalides felis. Am. J. Vet. Res. 2006, 67, 494–497. [Google Scholar] [CrossRef]
  27. Tasker, S.; Hofmann-Lehmann, R.; Belak, S.; Frymus, T.; Addie, D.D.; Pennisi, M.G.; Boucraut-Baralon, C.; Egberink, H.; Hartmann, K.; Hosie, M.J.; et al. Haemoplasmosis in cats: European guidelines from the ABCD on prevention and management. J. Feline Med. Surg. 2018, 20, 256–261. [Google Scholar] [CrossRef] [Green Version]
  28. Mylonakis, M.E.; Schreeg, M.; Chatzis, M.K.; Pearce, J.; Marr, H.S.; Saridomichelakis, M.N.; Birkenheuer, A.J. Molecular detection of vector-borne pathogens in Greek cats. Ticks Tick Borne Dis. 2018, 9, 171–175. [Google Scholar] [CrossRef]
  29. Maher, I.E.; Tasker, S.; Polizopoulou, Z.; Dasopoulou, A.; Egan, K.; Helps, C.R.; Papasouliotis, K. Polymerase chain reaction survey of feline haemoplasma infections in Greece. J. Feline Med. Surg. 2010, 12, 601–605. [Google Scholar] [CrossRef]
  30. Diakou, A.; Di Cesare, A.; Accettura, P.M.; Barros, L.; Iorio, R.; Paoletti, B.; Frangipane di Regalbono, A.; Halos, L.; Beugnet, F.; Traversa, D. Intestinal parasites and vector-borne pathogens in stray and free-roaming cats living in continental and insular Greece. PLoS Negl. Trop. Dis. 2017, 11, e0005335. [Google Scholar] [CrossRef] [Green Version]
  31. Chatzis, M.K.; Leontides, L.; Athanasiou, L.V.; Papadopoulos, E.; Kasabalis, D.; Mylonakis, M.; Rallis, T.; Koutinas, A.F.; Andreadou, M.; Ikonomopoulos, J.; et al. Evaluation of indirect immunofluorescence antibody test and enzyme-linked immunosorbent assay for the diagnosis of infection by Leishmania infantum in clinically normal and sick cats. Exp. Parasitol. 2014, 147, 54–59. [Google Scholar] [CrossRef]
  32. Kokkinaki, K.G.; Saridomichelakis, M.N.; Leontides, L.; Mylonakis, M.E.; Konstantinidis, A.O.; Steiner, J.M.; Suchodolski, J.S.; Xenoulis, P.G. A prospective epidemiological, clinical, and clinicopathologic study of feline leukemia virus and feline immunodeficiency virus infection in 435 cats from Greece. Comp. Immunol. Microbiol. Infect. Dis. 2021, 78, 101687. [Google Scholar] [CrossRef]
  33. Spada, E.; Proverbio, D.; Perego, R.; Canzi, I.; Baggiani, L.; De Maria, C.; Marino, F.; Caracappa, S. Screening Feline Blood Donors for Bartonella henselae Infection: Comparison between Indirect Immunofluorescent Antibody Test (IFAT) and Polymerase Chain Reaction (PCR) Results. J. Vet. Clin. Pract. Pet Care 2016, 1, 1–9. [Google Scholar] [CrossRef]
  34. Spada, E.; Canzi, I.; Baggiani, L.; Perego, R.; Vitale, F.; Migliazzo, A.; Proverbio, D. Prevalence of Leishmania infantum and co-infections in stray cats in northern Italy. Comp. Immunol. Microbiol. Infect. Dis. 2016, 45, 53–58. [Google Scholar] [CrossRef] [PubMed]
  35. Dowling, R.J.O.; Bienzle, D. Gene-expression changes induced by Feline immunodeficiency virus infection differ in epithelial cells and lymphocytes. J. Gen. Virol 2005, 86, 2239–2248. [Google Scholar] [CrossRef] [PubMed]
  36. Forootan, A.; Sjoback, R.; Bjorkman, J.; Sjogreen, B.; Linz, L.; Kubista, M. Methods to determine limit of detection and limit of quantification in quantitative real-time PCR (qPCR). Biomol. Detect. Quantif. 2017, 12, 1–6. [Google Scholar] [CrossRef] [PubMed]
  37. Jensen, W.A.; Lappin, M.R.; Kamkar, S.; Reagan, W.J. Use of a polymerase chain reaction assay to detect and differentiate two strains of Haemobartonella felis in naturally infected cats. Am. J. Vet. Res. 2001, 62, 604–608. [Google Scholar] [CrossRef] [PubMed]
  38. Diaz, M.H.; Bai, Y.; Malania, L.; Winchell, J.M.; Kosoy, M.Y. Development of a novel genus-specific real-time PCR assay for detection and differentiation of Bartonella species and genotypes. J. Clin. Microbiol. 2012, 50, 1645–1649. [Google Scholar] [CrossRef] [Green Version]
  39. Ye, J.; Coulouris, G.; Zaretskaya, I.; Cutcutache, I.; Rozen, S.; Madden, T.L. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 2012, 13, 134. [Google Scholar] [CrossRef] [Green Version]
  40. Mietze, A.; Morick, D.; Kohler, H.; Harrus, S.; Dehio, C.; Nolte, I.; Goethe, R. Combined MLST and AFLP typing of Bartonella henselae isolated from cats reveals new sequence types and suggests clonal evolution. Vet. Microbiol. 2011, 148, 238–245. [Google Scholar] [CrossRef]
  41. Barrs, V.R.; Beatty, J.A.; Wilson, B.J.; Evans, N.; Gowan, R.; Baral, R.M.; Lingard, A.E.; Perkovic, G.; Hawley, J.R.; Lappin, M.R. Prevalence of Bartonella species, Rickettsia felis, haemoplasmas and the Ehrlichia group in the blood of cats and fleas in eastern Australia. Aust. Vet. J. 2010, 88, 160–165. [Google Scholar] [CrossRef] [PubMed]
  42. Tiao, N.; Darrington, C.; Molla, B.; Saville, W.J.; Tilahun, G.; Kwok, O.C.; Gebreyes, W.A.; Lappin, M.R.; Jones, J.L.; Dubey, J.P. An investigation into the seroprevalence of Toxoplasma gondii, Bartonella spp., feline immunodeficiency virus (FIV), and feline leukaemia virus (FeLV) in cats in Addis Ababa, Ethiopia. Epidemiol. Infect. 2013, 141, 1029–1033. [Google Scholar] [CrossRef] [PubMed]
  43. Lobetti, R.G.; Tasker, S. Diagnosis of feline haemoplasma infection using a real-time PCR assay. J. S. Afr. Vet. Assoc. 2004, 75, 94–99. [Google Scholar] [CrossRef] [Green Version]
  44. Tasker, S.; Braddock, J.A.; Baral, R.; Helps, C.R.; Day, M.J.; Gruffydd-Jones, T.J.; Malik, R. Diagnosis of feline haemoplasma infection in Australian cats using a real-time PCR assay. J. Feline Med. Surg. 2004, 6, 345–354. [Google Scholar] [CrossRef] [PubMed]
  45. Tanahara, M.; Miyamoto, S.; Nishio, T.; Yoshii, Y.; Sakuma, M.; Sakata, Y.; Nishigaki, K.; Tsujimoto, H.; Setoguchi, A.; Endo, Y. An epidemiological survey of feline hemoplasma infection in Japan. J. Vet. Med. Sci. 2010, 72, 1575–1581. [Google Scholar] [CrossRef] [Green Version]
  46. Sykes, J.E.; Terry, J.C.; Lindsay, L.L.; Owens, S.D. Prevalences of various hemoplasma species among cats in the United States with possible hemoplasmosis. J. Am. Vet. Med. Assoc. 2008, 232, 372–379. [Google Scholar] [CrossRef]
  47. Mifsud, M.; Takacs, N.; Gyurkovszky, M.; Solymosi, N.; Farkas, R. Detection of flea-borne pathogens from cats and fleas in a maltese shelter. Vector Borne Zoonotic Dis. 2020, 20, 529–534. [Google Scholar] [CrossRef] [PubMed]
  48. Koutinas, A.F.; Papazahariadou, M.G.; Rallis, T.S.; Tzivara, N.H.; Himonas, C.A. Flea species from dogs and cats in northern Greece: Environmental and clinical implications. Vet. Parasitol. 1995, 58, 109–115. [Google Scholar] [CrossRef]
  49. Liodaki, M.; Spanakos, G.; Samarkos, M.; Daikos, G.L.; Christopoulou, V.; Piperaki, E.T. Molecular screening of cat and dog ectoparasites for the presence of Bartonella spp. in Attica, Greece. Acta Vet. Hung. 2022, 70, 9–14. [Google Scholar] [CrossRef]
  50. Woods, J.E.; Brewer, M.M.; Hawley, J.R.; Wisnewski, N.; Lappin, M.R. Evaluation of experimental transmission of Candidatus Mycoplasma haemominutum and Mycoplasma haemofelis by Ctenocephalides felis to cats. Am. J. Vet. Res. 2005, 66, 1008–1012. [Google Scholar] [CrossRef] [PubMed]
  51. Duplan, F.; Davies, S.; Filler, S.; Abdullah, S.; Keyte, S.; Newbury, H.; Helps, C.R.; Wall, R.; Tasker, S. Anaplasma phagocytophilum, Bartonella spp., haemoplasma species and Hepatozoon spp. in ticks infesting cats: A large-scale survey. Parasit. Vectors 2018, 11, 201. [Google Scholar] [CrossRef]
Figure 1. Map of the study area. Cats from the region of Attica, Crete, Macedonia and Thessaly were prospectively enrolled.
Figure 1. Map of the study area. Cats from the region of Attica, Crete, Macedonia and Thessaly were prospectively enrolled.
Vetsci 09 00337 g001
Table 1. Signalment and historical data of 452 cats selected for serology detection of B. henselae infection and of 242 cats selected for molecular detection of Bartonella spp. and haemoplasma species infections.
Table 1. Signalment and historical data of 452 cats selected for serology detection of B. henselae infection and of 242 cats selected for molecular detection of Bartonella spp. and haemoplasma species infections.
SerologyPCR
Signalment/Historical DataCategoriesNumber of Cats (%)Missing Data (%)Number of Cats (%)Missing Data (%)
Age (years, range, median) 0.125–17 (2)23 (5.1)0.125–15 (1)9 (3.7)
SexMale241 (53.3)0 (0)130 (53.7)0 (0)
Female211 (46.7)112 (46.3)
Neutered 138 (30.5)6 (1.3)71 (29.3)3 (1.2)
BreedPurebred15 (3.3)15 (3.3)2 (0.8)6 (2.5)
Common European422 (93.4)234 (96.7)
Living conditionsIndoors97 (21.5)22 (4.9)30 (12.4)7 (2.9)
Outdoors (exclusively or partially)333 (73.7)205 (84.7)
Geographic regionsAttica255 (56.4)0 (0)94 (38.8)0 (0)
Crete79 (17.5)70 (28.9)
Macedonia45 (10)18 (7.4)
Thessaly73 (16.2)60 (24.8)
Current ownershipClient-owned267 (59.1)9 (2)137 (56.6)2 (0.8)
Stray155 (34.3)91 (37.6)
Cattery21 (4.6)12 (5)
Living areaUrban361 (79.9)23 (5.1)176 (72.7)8 (3.3)
Rural68 (15)58 (24)
Health statusClinically healthy167 (36.9%)11 (2.4)74 (30.6)3 (1.2)
Sick274 (60.6)165 (68.2)
Table 2. Univariable associations between Bartonella henselae seropositivity and the signalment and historical data that were collected using a standardised questionnaire (Questionnaire S1).
Table 2. Univariable associations between Bartonella henselae seropositivity and the signalment and historical data that were collected using a standardised questionnaire (Questionnaire S1).
Bartonella henselae IgG Antibodies
VariablesCategoriesMissing DataSeropositive (%)Seronegative (%)p Value
SexMale078/160 (48.8%)163/292 (55.8%)0.15 a
Female 82/160 (51.2%)129/292 (44.2%)
Neutered 649/157 (31.2%)89/289 (30.8%)0.928
BreedPurebred152/154 (1.3%)13/283 (4.6%)0.071 a
Common European breed152/154 (98.7%)270/283 (95.4%)
Age (years) 232 (0.13–17)1 (0.13–15)<0.001 a
Cat acquisitionStray9387/118 (73.7%)170/241 (70.5%)0.529
Non-stray31/118 (26.3%)71/241 (29.5%)
Current ownershipClient-owned994/157 (59.9%)173/286 (60.5%)0.081 a
Stray60/157 (38.2%)95/286 (33.2%)
Cattery3/157 (1.9%)18/286 (6.3%)
Living conditionsIndoors2221/150 (14%)76/280 (27.1%)0.002 a
Outdoors129/150 (86%)204/280 (72.9%)
Living areaUrban23120/149 (80.5%)241/280 (86.1%)0.135 a
Rural29/149 (19.5%)39/280 (13.9%)
Geographic regionAttica097/160 (60.6%)158/292 (54.1%)0.024
Thessaly16/160 (10%)57/292 (19.5%)
Crete34/160 (21.3%)45/292 (15.4%)
Macedonia13/160 (8.1%)32/292 (11%)
Contact with other cats 57131/141 (92.9%)208/254 (81.8%)0.003 a
History of cat-fight trauma 25315/55 (27.3%)31/144 (21.5%)0.39
Use of ectoparasiticides 18756/91 (61.5%)101/174 (58%)0.583
Flea infestation 1143/156 (27.6%)44/285 (15.4%)0.002 a
Tick infestation 125/156 (3.2%)2/284 (0.7%)0.103 a
a Variables that were used in the logistic regression model (p value < 0.25).
Table 3. Multivariate analysis of signalment and historical data identified as factors associated with Bartonella henselae seropositivity and haemoplasma species PCR-positive status.
Table 3. Multivariate analysis of signalment and historical data identified as factors associated with Bartonella henselae seropositivity and haemoplasma species PCR-positive status.
VariablesCategoriesPositivity (%)ORCIp Value
1. Bartonella henselae
Age a 1.11.03–1.180.005
Living conditionsIndoors21/97 (21.6%)Reference
Outdoors129/333 (38.7%)2.171.2–3.950.02
Geographic regionThessaly16/73 (21.9%)Reference
Attica97/255 (38%)2.531.29–4.930.006
Crete34/79 (43%)2.951.35–6.280.006
Flea infestationNo113/354 (31.9%)Reference
Yes43/87 (49.4%)1.731.02–2.920.041
2. Haemoplasma species
Use of ectoparasiticidesNo21/80 (26.2%)Reference
Yes8/83 (9.6%)0.290.12–0.720.007
a In the present study, age was a continuous variable; OR: odds ratio; CI: confidence interval.
Table 4. Univariable associations between the infection status of 242 cats tested for haemoplasma species by PCR and the signalment and historical data that were collected using a standardised questionnaire (Questionnaire S1).
Table 4. Univariable associations between the infection status of 242 cats tested for haemoplasma species by PCR and the signalment and historical data that were collected using a standardised questionnaire (Questionnaire S1).
Haemoplasma Species PCR Status
VariablesCategoriesMissing DataPositive (%)Negative (%)p Value
SexMale025/46 (54.3%)105/196 (53.6%)0.924
Female 21/46 (45.7%)91/196 (46.4%)
Neutered 311/45 (24.4%)60/194 (30.9%)0.391
BreedPurebred60/44 (0%)44/44 (100%)1
Crossbreed 2/190 (1%)190/192 (99%)
Age (years) 92 (0.13–8)1 (0.13–15)0.705
Cat acquisitionClient-owned 9/32 (28.1%)47/152 (30.9%)0.879
Stray5820/32 (62.5%)92/152 (60.5%)
Cattery 3/32 (9.4%)11/152 (7.2%)
Pet shop 0/32 (0%)2/152 (1.3%)
Current ownershipClient-owned 22/45 (48.9%)115/195 (59%)0.453
Stray220/45 (44.4%)71/195 (36.4%)
Cattery 3/45 (6.7%)9/195 (4.6%)
Living conditionsIndoors72/44 (4.5%)28/191 (14.7%)0.07 a
Outdoors 42/44 (95.5%)163/191 (85.3%)
Living areaUrban831/44 (70.5%)145/190 (76.3%)0.417
Rural 13/44 (29.5%)45/190 (23.7%)
Geographic regionAttica 12/46 (26.1%)82/196 (41.8%)0.238
Thessaly013/46 (28.3%)47/196 (24%)
Crete 16/46 (34.8%)54/196 (27.6%)
Macedonia 5/46 (10.9%)13/196 (6.6%)
Contact with other cats 1143/44 (97.7%)174/187 (93%)0.479
History of cat-fight trauma 1204/19 (21.1%)24/103 (23.3%)1
Use of ectoparasiticides 798/29 (27.6%)75/134 (56%)0.006 a
Flea infestation 614/45 (31.1%)49/191 (25.7%)0.457
Tick infestation 71/45 (2.2%)4/190 (2.1%)1
PCR: polymerase chain reaction. a Variables that were used in the logistic regression model (p value < 0.25).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kokkinaki, K.C.G.; Saridomichelakis, M.N.; Skampardonis, V.; Mataragka, A.; Ikonomopoulos, J.; Leontides, L.; Mylonakis, M.E.; Steiner, J.M.; Suchodolski, J.S.; Xenoulis, P.G. Prevalence and Risk Factors for Bartonella spp. and Haemoplasma Infections in Cats from Greece. Vet. Sci. 2022, 9, 337. https://doi.org/10.3390/vetsci9070337

AMA Style

Kokkinaki KCG, Saridomichelakis MN, Skampardonis V, Mataragka A, Ikonomopoulos J, Leontides L, Mylonakis ME, Steiner JM, Suchodolski JS, Xenoulis PG. Prevalence and Risk Factors for Bartonella spp. and Haemoplasma Infections in Cats from Greece. Veterinary Sciences. 2022; 9(7):337. https://doi.org/10.3390/vetsci9070337

Chicago/Turabian Style

Kokkinaki, Kassiopi Christina G., Manolis N. Saridomichelakis, Vassilis Skampardonis, Antonia Mataragka, John Ikonomopoulos, Leonidas Leontides, Mathios E. Mylonakis, Joerg M. Steiner, Jan S. Suchodolski, and Panagiotis G. Xenoulis. 2022. "Prevalence and Risk Factors for Bartonella spp. and Haemoplasma Infections in Cats from Greece" Veterinary Sciences 9, no. 7: 337. https://doi.org/10.3390/vetsci9070337

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop